The article reports that the U.S. Food and Drug Administration (FDA) has approved the drug Rinvoq as a treatment for moderate to severe Crohn's disease in adults who have not responded or tolerated treatment with one or more tumor necrosis factor blockers.
Processing Request
No Comments.